Recent Finacing
Recent Raise
Myria Biosciences applies synthetic biology, AI, and super‑high‑throughput screening via its GEMMS platform that engineers cells to generate and screen millions of natural product–inspired molecules weekly for drug discovery.
Focus Areas
Recent Investors
Funding round
Investors